目前和新兴的治疗方法 C3 淋巴结膜病变和初级 (原发性) 免疫复合体膜增殖性淋巴结膜炎
David Kavanagh1,2, Gema Ariceta3, Marina Vivarelli4
1Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK.
Kidney international reports
|January 16, 2026
概括
向补充抑制剂对C3型血小板病变 (C3G) 和免疫复合体膜增殖性血小板炎 (IC-MPGN) 有希望. 这些疗法解决了潜在的补体调节障碍,为患有这些罕见病的患者提供了新的希望.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- C3型血小板病 (C3G) 和原发性免疫复合体膜增殖血小板炎 (IC-MPGN) 是由补体系统失调驱动的罕见脏疾病.
- 这些条件导致C3沉积在质体中,导致功能衰竭,在10年内,多达50%的患者出现功能衰竭.
- 传统治疗侧重于支持性护理和免疫抑制,缺乏针对潜在病理的特定疗法.
研究的目的:
- 审查关于C3G和IC-MPGN中的补充抑制剂的当前理解和剩余问题.
- 评估补充剂抑制剂对蛋白尿,EGFR和组织学等关键疗效终点的影响.
- 讨论围绕患者选择,治疗持续时间和对补充抑制剂治疗的监测的争议.
主要方法:
- 对补充剂抑制剂 (iptacopan 和 pegcetacoplan) 最近的第三期临床试验数据的审查.
- 对C3G和IC-MPGN.治疗疗效的替代终点的分析.
- 讨论临床争议和补充抑制剂治疗的未来方向.
主要成果:
- 伊普塔科班 (B因子抑制剂) 和佩格塞塔科普兰 (C3/C3b抑制剂) 的第三期试验在成人和青少年中显示出积极的结果,这些患者患有C3G或IC-MPGN.
- 这些向疗法解决了潜在的补体调节障碍,与以前的治疗策略相比,这是一个显著的进步.
- 该审查综合了替代疗效标记的数据,包括蛋白尿,eGFR和组织学改善.
结论:
- 向补充抑制剂代表了C3G和IC-MPGN的显著治疗进展,提供了改善的预后.
- 关于最佳患者群体,治疗持续时间和监测策略,需要进一步的研究和共识.
- 这些创新疗法对患者具有有史以来不良的长期结果有希望.
相关概念视频
Chronic Kidney Disease III: Interprofessional Care
344
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
344
Nephrotic Syndrome III : Nursing Management
282
Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
282
Nephrotic Syndrome II : Assessment and Medical Management
203
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
203
Open Angle Glaucoma: Treatment
963
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
963
Myocarditis III: Medical Management
175
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
175
Acute Kidney Injury IV: Diagnostic Studies and Prevention
271
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
271


